The methods used to produce transgenic animals are still being improved. One new approach for generating transgenic animals is based on mobile genetic elements (transposons), which are integrated into the host genome by transposase. Transposon systems, such as Minos, Tol1, Tol2, piggyBac and Sleeping Beauty, have been used to modify invertebrates, fish, frogs and mammals (KAWAKAMI et al. 2000; DUPUY et al. 2002; SASAKURA et al. 2003; WILBER et al. 2006; SUMIYAMA et al. 2010) . Among these systems, piggyBac, Tol2 and Sleeping Beauty have been used to transfer foreign genes into the avian genome, but only piggyBac and Tol2 transposons have been applied to produce transgenic chickens (MACDONALD et al. 2012; WANG et al. 2016) .
Transgenic chickens are generated primarily through chimeric intermediates via the transfer of modified primordial germ cells (PGCs) into recipient embryos (KUWANA 1993; NAITO 2003; ZHU et al. 2005 ; VAN DE LAVOIR et al. 2006; NAKAMURA et al. 2010; CHOJNACKA-PUCHTA et al. 2015; NAITO 2015) . A previous study (MACDONALD et al. 2012) showed that application of the piggyBac or Tol2 transposon systems improved DNA transfer into PGCs. Furthermore, this system has important advantages, as it effectively inserts exogenous DNA into the host chromosome without transgene expression silencing (MACDONALD et al. 2012; PARK & HAN 2012; GLOVER et al. 2013; NAITO 2015) . Therefore, transposable elements are efficient vectors for the genetic manipulation of PGCs and the chicken genome. The transfection method also plays a critical role during the transfer of DNA into PGCs. Previous studies (MACDONALD et al. 2012; PARK & HAN 2012; GLOVER et al. 2013; LIU et al. 2013) showed that the use of transposon vectors in combination with lipofection is a promising approach for cell modification.
Here, we optimized transfection conditions with new Tol2 transposon vectors carrying gene expression cassettes, insulators and enhancer elements using the Chinese Hamster Ovary cell line (CHO-K1). We investigated the effects of cell density, lipofection conditions and plasmid constructs on in vitro transgene expression, as determined by FACS (Fluorescence-activated cell sorter). CHO-K1 cells were a suitable model for evaluating the effects of these factors; thus, we reduced the number of chicken embryos used as donors of PGCs. We modified chicken PGCs by using the most effective transfection protocol identified for CHO-K1 cells.
Materials and Methods

Plasmid construction
The miniTol2 plasmid system used in this study was described by BALCIUNAS et. al. (2006) . The vectors pL-miniTol2-OVA5IFN and pLminiTol2-OVA5Egfp were constructed on the miniTol2 backbone. The first plasmid contains Tol2 transposon with mini ITRs and the terminal Tol2 sequences flanking the pOVA promoter driving the enhanced human IFNalfa2a gene. The second plasmid expresses EGFP (GFPmut1 variant, Promega) under the control of the chicken ovalbumin promoter, including the enhancer and regulatory sequences. The third plasmid contains the Tol2 transposase sequence under the control of the CMV promoter (plasmid from Stephen Ekker, Addgene plasmid # 31823 http://n2t.net/addgene:31823; RRID:Addgene_31823). Based on the pSF-CMV-RSV-Neo_G418 OXFORD vector we constructed a donor vector: pL-OG-OVAIFNEnhEgfp. This vector contains a Neomycin/G418 resistance expression cassette under the control of the RSV promoter. The human IFNalfa2a gene with SV40 enhancer is under ovalbumin promoter. This plasmid also contains the mammalian CMV promoter to drive EGFP expression. Plasmids used in this study are presented in Fig. 1 .
CHO-K1 cell culture
Chinese hamster ovary cells (CHO-K1, ATCC CCL-61) were maintained in Iscove's Modified Dulbecco's Medium (IMDM, Sigma-Aldrich, St. Louis, MO, USA) supplemented with 10% fetal bovine serum (FBS, Sigma-Aldrich), 4 mM Lglutamine (Sigma-Aldrich) and 0.5% antibiotic antimycotic solution (100x Penicillin-Streptomycin-Amphotericin B, Sigma) in a humidified 5% CO 2 incubator at 37°C. The cells were cultured in 100 mm plates (Corning, N.Y, USA) and passaged before reaching full confluency. To detach cells from the culture plates, 5 mM EDTA solution (Gibco, Invitrogen, Carlsbad, CA, USA) was used.
PGC culture
PGCs were isolated from the bloodstream of Ross 308 embryos (Malec H. Poultry Farm, Góra Kalwaria, Poland) at stage 14-16 (Hamburger Hamilton, H.H.) and incubated in a FEST incubator (Gostyñ, Poland) at 37.8°C with 60-62% relative humidity. The isolated PGCs were purified via Percoll gradient density centrifugation, as previously described by OISHI (2010) . Purified PGCs were seeded in 24-well plates (Nunc, Roskilde, Denmark) in OPTIMEM C medium [OPTIMEM (Gibco Invitrogen) supplemented with 10% FBS, 2% chicken serum (Gibco Invitrogen), 9 ng/ml murine leukemia inhibitory factor (SigmaAldrich), 20 ng/ml basic fibroblast growth factor (Sigma-Aldrich), 5 ng/ml human stem cell factor (Sigma-Aldrich) and 1× penicillin/streptomycin (Sigma-Aldrich) SAWICKA et al. 2015) ] and incubated at 37°C with 5% CO 2 .
Optimization of the lipofection protocol using CHO-K1 cells
One day before transfection, cells were seeded in 24-well or 6-well plates (Nunc) at a density of 1 x 10 5 or 5 x 10 5 cells/ml, respectively. Transfections were performed with the Xtreme HP DNA transfection reagent (Roche Diagnostics, Rotkreuz, Switzerland) using different protocols, with the transposon vector pCMV-Tol2 and pL-miniTol2-OVA5IFN or pL-miniTol2-OVA5Egfp at the following ratios: 0.5 µg: 1 µg (A), 1 µg: 0.5 µg (B) and 1 µg: 1 µg (C) in the presence of 1 µl of lipofectant for 1 x 10 5 cells/ml or 2 µl of lipofectant for 5 x 10 5 cells/ml. Lipofections were also performed using the nontransposon vector pL-OGOVAIFNEnh-Egfp (as a control) at a ratio of 1 µg: 3 µl of lipofectant (protocol D). Complexes of DNA-liposomes were added to cells in a dropwise manner after 20 min of incubation at room temperature (RT). After culturing the cells for 24 h, antibiotic for selection (G418, 0.4 mg/ml, SigmaAldrich) was added. The transfection reagent was removed after 48 h of culture, and the cells were maintained for the next 24 h in selective medium. The successfully transfected cells compared to nontransfected produced the enzyme digesting G418, therefore cells survived. The cells were analyzed using flow cytometry (FACS Aria, BD Biosciences, San Jose, CA, USA) after staining with PI (propidium iodide, BD Biosciences). We performed four replicates for each combination of applied factors.
Transfection of PGCs
Purified PGCs were transfected with the most effective lipofection conditions identified in CHO-K1 cells. Briefly, purified PGCs were seeded in 24-well plates at a density of 1 x 10 5 or 5 x 10 5 cells/ml and cotransfected with method A (0.5 µg of pCMV-Tol2 with 1 µg of pL-miniTol2-OVA5IFN/pL-miniTol2-OVA5Egfp and 1 µl of lipofectant). The cells were also transfected using the nontransposon vector pL-OG-OVAIFNEnh-Egfp (as a control) at a ratio of 1 µg: 3 µl of lipofectant (protocol D). Lipofections were performed as described above. After 24 h of culturing cells in OPTIMEM C medium, G418 (0.4 mg/ml) was added. The medium was changed after 24 h, and the cells were cultured in selective medium until FACS analysis. Every experiment was carried out in triplicate.
Determination of transfection efficiency via FACS analysis
Cell transfection efficiencies (CHO-K1 and PGCs) were determined based on viability. The cells were centrifuged (5 min at 1,000 rpm at 21°C) and stained with PI (BD Biosciences) according to the manufacturer's recommendations. Briefly, the cells were washed twice with cold 1x PBS (phosphate-buffered saline, Gibco Invitrogen) and subsequently suspended in 1× Binding Buffer. Then, 1 x 10 5 cells/ml were transferred to a 5 ml culture tube, and 5 ìl of PI was added. The specimens were gently vortexed and incubated for 15 min at RT (25°C) in the dark. Next, 400 ìl of 1 × Binding Buffer was added to each tube, and the specimens were analyzed by FACS. The fluorescence of PI was detected at an excitation wavelength of 488 nm using the 605/75 filter. PGCs were also observed under a confocal microscope (TE2000-E, Nikon Corporation, Tokyo, Japan).
Statistical analysis
We calculated differences in the viability of CHO-K1 cells transfected with various cell densities, plasmid constructs and lipofection protocols with three-factor analysis of variance followed by the Bonferroni and Games-Howell tests. To examine differences in the viability of PGCs after lipofection with different plasmid constructs at various cell densities, two-way analysis of variance was performed. Analysis of variance took into account interactions between applied factors. 
Results
Flow cytometric analysis of CHO-K1 cell transfection efficiency
The CHO-K1 cells analyzed by FACS before lipofection exhibited high viability (95.5±1.5%). These cells were transfected under various conditions. We used cell viability as a measure of transfection efficiency. The effectiveness of cell lipofection was examined by flow cytometric analysis after the cells had been subjected to G418 selection. The percentage of transfected cells was significantly higher (p<0.05) after transfection at a density 1 x 10 5 cells/ml than after transfection at a density of 5 x 10 5 cells/ml. There were significant differences (p<0.05) in viability between cells transfected with nontransposon vectors via protocol D and cells transfected with transposon vectors using protocols B and C (Figs 2-3) . However, among the transposon vectors, the highest transfection efficiency was achieved after lipofection of cells at a density of 1 x 10 5 cells/ml with the pCMV-Tol2 and pL-miniTol2-OVA5IFN vectors using protocol A (62±1%) (Fig. 2) . The combination of a cell density of 5 x 10 5 cells/ml, pCMV-Tol2 with pL-miniTol2-OVA5Egfp and protocol C yielded the lowest percentage of transfected cells (13±1.5%) (Fig. 3) . 
Effectiveness of PGC transfection assessed by FACS analysis
The viability of freshly isolated and purified PGCs was high (98.9±1%) (Fig. 4) . These cells were transfected with the most effective lipofection conditions identified in CHO-K1 cells. The percentage of live cells was used as a measure of in vitro transgene expression efficiency. We analyzed transfection efficiency by FACS analysis after the cells had been cultured with G418 selection. We found significant (p<0.05) differences in cell viability between cells transfected at a density of 1 x 10 5 cells/ml and cells transfected at a density of 5 x 10 5 cells/ml (Fig. 5) . Similarly, in CHO-K1 cells transfected with transposon vectors via protocol A and pL-OG-OVAIFNEnh-Egfp via protocol D, the percentage of viable cells did not differ significantly (Fig. 5) . However, among transposon vectors, the highest percentage of transfected cells was 67±0.5%; this percentage was achieved by transfecting the cells with pCMV-Tol2 and pL-miniTol2-OVA5IFN at a density of 5 x 10 5 cells/ml. The most unfavorable transfection conditions for PGCs were a density of 1 x 10 5 cells/ml with pCMV-Tol2 and pL-miniTol2-OVA5Egfp (56.8±1.8%) (Fig. 5) .
Discussion
PiggyBac and Tol2 transposons enable the introduction of exogenous DNA into host chicken chromosomes without silencing and increase the frequency of transgene integration in chicken PGCs, thereby greatly enhancing the efficient production of transgenic chickens (MACDONALD et al. 2012; PARK & HAN 2012) . The efficiency of transgenic chicken generation also depends on PGC transfection efficiency, which in turn depends on the method used to introduce transposon vectors into PGCs. Previous studies have shown that transposons can be introduced with electroporation (SATO et al. 2007; LIU et al. 2013) or nucleofection (NAITO 2015) . Nucleofection is a useful tool to transfect cells, but it requires specialized equipment and accessories, making it expensive and limiting its availability in the laboratory. The best alternative to electroporation, which achieves higher gene transfer efficiency, viability of manipulated embryos and hatching rates, is a combination of transposons and lipofection (TYACK et al. 2013) .
In our study, we used lipofection as a transfection method to modify cells in combination with Tol2 transposon vectors carrying gene expression cassettes, insulators and enhancer elements. Our research focused on two areas. First, we optimized lipofection conditions using commercially available CHO-K1 cells. CHO-K1 cells are a good model for evaluating the effects of different factors, such as cell density, lipofection conditions and plasmid constructs, on transfection efficiency; thus, we reduced the number of chicken embryos used as PGC donors. Second, we transfected purified PGCs with the most effective lipofection protocol identified for CHO-K1 cells.
Lipofection in combination with transposons has been used to transfect both PGCs and CHO-K1 cells (BALASUBRAMANIAN et al. 2011; MATASCI et al. 2011; MACDONALD et al. 2012; PARK & HAN 2012; GLOVER et al. 2013; LIU et al. 2013; RAJENDRA et al. 2016) . In these studies, transposon vectors were combined with different transfection reagents, such as Lipofectamine 2000, 1,2-dimyristyloxy-propyl-3-dimethyl-hydroxy ethyl ammonium bromide (DMRIE) and polyethylenimine (PEI). This is the first report using X-treme Gene HP to transfect cells with transposon vectors. As reported in previous studies (OISHI 2010; MATÁS et al. 2011; CHOJNACKA-PUCHTA et al. 2015) , the uptake of foreign DNA by PGCs and thereby transfection efficiency can be increased by Percoll purification. Because PGCs have a lower proliferation rate than CHO-K1 cells (VAN DE LAVOIR et al. 2006; KONG et al. 2018 ) and require suspension culture conditions, purified cells were seeded at two densities: 1 x 10 5 cells/ml and 5 x 10 5 cells/ml in 24-well plates. We transfected purified PGCs with transposon vectors via method A or nontransposon vectors via method D. After selection in G418-containing medium, cell viability was examined by flow cytometry. The most appropriate transfection conditions for introducing transposon vectors into PGCs were lipofection at a density of 5 x 10 5 cells/ml with method A (Fig. 5) . This procedure achieved a transfection efficiency of 67±0.5%. In a study by MACDONALD et al. (2012) , PGCs were transfected with transposon vectors combined with lipofection (via DMRIE transfection reagent), and 45.2% of cells were transfected. We show that our optimized method is effective and can be used to transfect PGCs with transposon vectors. Modified in this way, PGCs, injected into the bloodstream of recipient embryos, may be useful for producing transgenic chickens via chimeric intermediates (KUWANA 1993; VAN DE LAVOIR et al. 2006; NAKAMURA et al. 2010; CHOJNACKA-PUCHTA et al. 2015; NAITO 2015) .
Introduction of exogenous DNA into PGCs is also possible by in vivo transfection. Unlike in vitro transfection, this method is based on direct injection of DNA-liposome/-PEI complexes into the subgerminal cavity of newly laid eggs or into the vasculature of developing chicken embryos. WANG et al. (2016) performed PGC transfections in vivo using different transposon vectors (PB, SB, TOL2 or ZB) combined with transfection reagent (PEI) and obtained 65-70% nonviable hatched individuals. In vitro transfection enables to select the most effective methods for transposon vectors before generating transgenic chickens.
In conclusion, this is the first study to optimize cell lipofection using transposon vectors. We presented an effective method for the transfection of chicken PGCs with the use of transposon vectors combined with lipofection. The method employed in this work will facilitate the production of transgenic chickens in future projects.
